These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 12722692)

  • 21. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of new Japanese GCP on pharmaceutical-company-directed clinical trials and physician-directed clinical studies in the surgical field].
    Nakajima T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):685-90. PubMed ID: 9571965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
    Takimoto CH
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):703-9. PubMed ID: 18615251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Improving the infrastructure for clinical trials in Japan].
    Nakano S
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):225-30. PubMed ID: 9987523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
    Hudis CA; Barlow WE; Costantino JP; Gray RJ; Pritchard KI; Chapman JA; Sparano JA; Hunsberger S; Enos RA; Gelber RD; Zujewski JA
    J Clin Oncol; 2007 May; 25(15):2127-32. PubMed ID: 17513820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan.
    Uyama Y; Shibata T; Nagai N; Hanaoka H; Toyoshima S; Mori K
    Clin Pharmacol Ther; 2005 Aug; 78(2):102-13. PubMed ID: 16084844
    [No Abstract]   [Full Text] [Related]  

  • 27. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The progress of second-line chemotherapy and molecular targeting agents in gastric cancer].
    Takiuchi H
    Gan To Kagaku Ryoho; 2009 May; 36(5):717-20. PubMed ID: 19461169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. End points in cancer clinical trials and the drug approval process.
    Schilsky RL
    Clin Cancer Res; 2002 Apr; 8(4):935-8. PubMed ID: 11948095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The guideline for clinical trials proposed by Japan Society for Cancer Therapy (JSCT)].
    Kurihara M
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):156-65. PubMed ID: 8611043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gynecologic cancer].
    Uehara T; Katsumata N
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1488-94. PubMed ID: 18799902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating clinical trials into meaningful outcomes.
    LoRusso PM; Schnipper LE; Stewart DJ; Boerner SA; Averbuch SD; Wolf W
    Clin Cancer Res; 2010 Dec; 16(24):5951-5. PubMed ID: 21169247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Introduction: "The scope of this forum" and "the necessity of introduction of compassionate use system in Japan"].
    Fujiwara Y
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):281-3. PubMed ID: 17301543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Infrastructure for new drug development to treat muscular dystrophy: current status of patient registration (remudy)].
    Nakamura H; Kimura E; Kawai M
    Brain Nerve; 2011 Nov; 63(11):1279-84. PubMed ID: 22068481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecule based diagnosis].
    Akaza H; Ichikawa T; Tsuruo T; Shimada Y; Moriwaki H; Mori M; Noguchi S; Nakamura S; Saijo N; Sone S; Isonishi S; Ohashi Y; Hinotsu S; von Euler M; Blackedge G
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):125-33. PubMed ID: 14750337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tuberculosis and its control--lessons from the past and future prospect].
    Shimao T
    Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials and approval of anti-cancer agents.
    Iwasaki M; Hinotsu S; Katsura J
    Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i65-69. PubMed ID: 20870922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Participation in the international multi-countries study-operational issues from company view point].
    Hada S
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):324-7. PubMed ID: 17301555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Operational aspect of participation in the multi-national clinical trials from the foreign pharmaceutical company's standpoint].
    Namazu K
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):328-30. PubMed ID: 17301556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.